An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma

British Journal of Surgery

Volumn 91, Issue 1, 2004, Pages 99-104

  Tajima, Y ^a   Kuroki, T ^a   Fukuda, K ^a   Tsuneoka, N ^a   Furui, J ^a   Kanematsu, T ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; INTRAHEPATIC BILE DUCT; LIVER RESECTION; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PERINEURIUM; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 1642499214     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4366     Document Type: Article

References (36)

1. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211: 277-287.
2. Bhuiya MR, Nimura Y, Kamiya J, Kondo S, Fukata S, Hayakawa N et al. Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 1992; 215: 344-349.
3. Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990; 159: 91-97.
4. Cherqui D, Tantawi B, Alon R, Piedbois P, Rahmouni A, Dhumeaux D et al. Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch Surg 1995; 130: 1073-1078.
5. Chou FF, Sheen-Chen SM, Chen CL, Chen YS, Chen MC. Prognostic factors of resectable intrahepatic cholangiocarcinoma. J Surg Oncol 1995; 59: 40-44.
6. Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen CL. Surgical treatment of cholangiocarcinoma. Hepatogastroentarology 1997; 44: 760-765.
7. Chu KM, Lai EC, Al-Hadeedi S, Arcilla CE Jr, Lo CM, Liu CL et al. Intrahepatic cholangiocarcinoma. World J Surg 1997; 21: 301-305.
8. Jan YY, Jeng LB, Hwang TL, Wang CS, Chen MF, Chen TJ. Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology 1996; 43: 614-619.
9. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-473.
10. Sano T, Kamiya J, Nagino M, Uesaka K, Kondo S, Kanai M et al. Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999; 6: 101-107.
11. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995; 130: 270-276.
12. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol 1998; 69: 162-167.
13. Tajima Y, Eto T, Tsunoda T, Tomioka T, Inoue K, Fukahori T et al. Induction of extrahepatic biliary carcinoma by N-nitrosobis(2-oxopropyl)amine in hamsters given cholecystoduodenostomy with dissection of the common duct. Jpn J Cancer Res 1994; 85: 780-788.
14. Fukahori T, Tomioka T, Inoue K, Tajima Y, Tsunoda T, Kanematsu T. Establishment of a transplantable carcinoma arising from the intrahepatic bile duct in Syrian golden hamsters. Virchows Arch A Pathol Anat Histopathol 1993; 422: 233-238.
15. Inoue K, Tomioka T, Tajima Y, Fukahori T, Eto T, Tsunoda T et al. Characterization of an established transplantable adenocarcinoma of the gallbladder in Syrian golden hamster. J Surg Oncol 1994; 56: 269-276.
16. Ikematsu Y, Tomioka T, Yamanaka S, Tajima Y, Tsunoda T, Kanematsu T. Bilioenterostomy enhances biliary carcinogenesis in hamsters. Carcinogenesis 1996; 17: 1505-1509.
17. Yamanaka S, Tomioka T, Tajima Y, Okada K, Shiku H, Kanematsu T. K-ras gene mutations in intrahepatic bile duct tumors of Syrian golden hamsters. J Surg Oncol 1997; 66: 97-103.
18. Ikematsu Y, Tomioka T, Kitajima T, Inoue K, Tajima Y, Kanematsu T. Tauroursodeoxycholate and cholestyramine enhance biliary carcinogenesis in hamsters. World J Surg 2000; 24: 22-26.
19. Kitajima T, Tajima Y, Onizuka S, Matsuzaki S, Matsuo K, Kanematsu T. Linkage of persistent cholangitis after bilioenterostomy with biliary carcinogenesis in hamsters. J Exp Clin Cancer Res 2000; 19: 453-458.
20. Liver Cancer Study Group of Japan. Macroscopic typing of intrahepatic cholangiocarcinoma. In Classification of Primary Liver Cancer (1st English edn). Kanehara-Shuppan: Tokyo, 1997; 6-7.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
22. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
23. Cox DR. Regression models and life tables. JR Stat Soc 1972; 34: 187-200.
24. Nakajima T, Kondo Y, Miyazaki M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 1988; 19: 1228-1234.
25. Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983; 139: 217-238.
26. Ohashi K, Nakajima Y, Tsutsumi M, Kanehiro H, Fukuoka T, Hisanaga M et al. Clinical characteristics and proliferating activity of intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol 1994; 9: 442-446.
27. Suh KS, Roh HR, Koh YT, Lee KU, Park YH, Kim SW. Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 2000; 31: 12-17.
28. Sakamoto, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M et al. Clinicopathological studies of mucin-producing cholangiocarcinoma. J Hepatobiliary Pancreat Surg 1997; 4: 157-162.
29. Cuillerier E, Cellier C, Palazzo L, Deviere J, Wind P, Rickaert F et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000; 95: 441-445.
30. Falconi M, Salvia R, Bassi C, Zamboni G, Talamini G, Pederzoli P. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 2001; 88: 376-381.
31. Zamora C, Sahel J, Cantu DG, Heyries L, Bernard JP, Bastid C et al. Intraductal papillary or mucinous tumors (IPMT) of the pancreas: report of a case series and review of the literature. Am J Gastroenterol 2001; 96: 1441-1447.
32. Corlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996; 223: 273-279.
33. Fukushima N, Sakamoto M, Mukai K, Kanai Y, Shimada K, Kosuge T et al. Intraductal papillary components in invasive ductal carcinoma of the pancreas are associated with long-term survival of patients. Hum Pathol 2001; 32: 834-841.
34. Kawahira H, Hasebe T, Kinoshita T, Sasaki S, Konishi M, Nakagori T et al. The intraductal carcinoma component is a significant prognostic parameter in patients with invasive ductal carcinoma of the pancreas. Jpn J Cancer Res 2002; 93: 1138-1144.
35. Silverberg SG, Chitale AR. Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast. Cancer 1973; 32: 830-837.
36. Sasaki A, Aramaki M, Kawano K, Morii Y, Nakashima K, Yoshida T et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg 1998; 85: 1206-1209.